Skip to Content Skip to Navigation

BREAST CANCER
NEEDS A
PERSONALISED
APPROACH

New and improved treatment

While hormone and targeted therapies, such as Tamoxifen and Herceptin, have had a major impact on improving survival rates for those living with breast cancer, they are only effective for patients with hormone-responsive (oestrogen-receptor positive) or HER2-positive disease. Treatment options for some other types of breast cancer, like triple-negative breast cancer or those with advanced disease, are more limited.

In addition to finding treatment options for these harder-to-treat breast cancers, some of the other major clinical challenges include trying to find ways to reduce the side effects of treatments that can often severely impact the quality of life of people with breast cancer, and finding alternative treatments for when breast cancer develops resistance.

The research that we fund

NBCF funds novel and innovative scientific research to uncover new and better therapeutic strategies to improve treatment effectiveness and reduce potential side effects. Our funded projects include developing new and improved approaches to:

  • Treat advanced breast cancer
  • Harness the patient’s immune system to fight cancer (immunotherapy)
  • Personalise cancer treatment to the individual